Literature DB >> 20149679

Vitamin D: newly discovered actions require reconsideration of physiologic requirements.

Daniel D Bikle1.   

Abstract

Vitamin D is not just for preventing rickets and osteomalacia. Recent findings in animal experiments, epidemiologic studies and clinical trials indicate that adequate vitamin D levels are important for cancer prevention, controlling hormone levels and regulating the immune response. Although 25 hydroxyvitamin D (25OHD) levels >10 ng/ml can prevent rickets and osteomalacia, these levels are not sufficient to provide these more recently discovered clinical benefits. Rather, levels of 25OHD >30 ng/ml are generally recommended. Determining optimal levels of 25OHD and the amount of vitamin D supplementation required to achieve those levels for the numerous actions of vitamin D will only be established with additional trials. In this review, these newer applications are summarized and therapeutic considerations are provided. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20149679      PMCID: PMC2880203          DOI: 10.1016/j.tem.2010.01.003

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  81 in total

Review 1.  Intervention in autoimmunity: the potential of vitamin D receptor agonists.

Authors:  Luciano Adorini
Journal:  Cell Immunol       Date:  2005-02       Impact factor: 4.868

Review 2.  Prevention of chronic allograft rejection by Vitamin D receptor agonists.

Authors:  Luciano Adorini; Susana Amuchastegui; Kenn C Daniel
Journal:  Immunol Lett       Date:  2005-08-15       Impact factor: 3.685

3.  An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia.

Authors:  Anna Benet-Pagès; Peter Orlik; Tim M Strom; Bettina Lorenz-Depiereux
Journal:  Hum Mol Genet       Date:  2004-12-08       Impact factor: 6.150

Review 4.  Overview of general physiologic features and functions of vitamin D.

Authors:  Hector F DeLuca
Journal:  Am J Clin Nutr       Date:  2004-12       Impact factor: 7.045

5.  Vitamin D2 is much less effective than vitamin D3 in humans.

Authors:  Laura A G Armas; Bruce W Hollis; Robert P Heaney
Journal:  J Clin Endocrinol Metab       Date:  2004-11       Impact factor: 5.958

6.  Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3.

Authors:  Adrian F Gombart; Niels Borregaard; H Phillip Koeffler
Journal:  FASEB J       Date:  2005-07       Impact factor: 5.191

7.  Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer.

Authors:  Elizabeth R Bertone-Johnson; Wendy Y Chen; Michael F Holick; Bruce W Hollis; Graham A Colditz; Walter C Willett; Susan E Hankinson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-08       Impact factor: 4.254

8.  Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems.

Authors:  Wei Xiang; Juan Kong; Songcang Chen; Li-Ping Cao; Guilin Qiao; Wei Zheng; Wenhua Liu; Xinmin Li; David G Gardner; Yan Chun Li
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-09-14       Impact factor: 4.310

Review 9.  Enzymes involved in the activation and inactivation of vitamin D.

Authors:  David E Prosser; Glenville Jones
Journal:  Trends Biochem Sci       Date:  2004-12       Impact factor: 13.807

10.  Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London.

Authors:  A Ustianowski; R Shaffer; S Collin; R J Wilkinson; R N Davidson
Journal:  J Infect       Date:  2005-06       Impact factor: 6.072

View more
  70 in total

Review 1.  Role of autophagy in the host response to microbial infection and potential for therapy.

Authors:  Mario Fabri; Susan E Realegeno; Eun-Kyeong Jo; Robert L Modlin
Journal:  Curr Opin Immunol       Date:  2010-11-09       Impact factor: 7.486

2.  VDR and CYP27B1 are expressed in C2C12 cells and regenerating skeletal muscle: potential role in suppression of myoblast proliferation.

Authors:  Ratchakrit Srikuea; Xiping Zhang; Ok-Kyong Park-Sarge; Karyn A Esser
Journal:  Am J Physiol Cell Physiol       Date:  2012-05-30       Impact factor: 4.249

Review 3.  New vitamin D analogs as potential therapeutics in melanoma.

Authors:  Paulina Szyszka; Michal A Zmijewski; Andrzej T Slominski
Journal:  Expert Rev Anticancer Ther       Date:  2012-05       Impact factor: 4.512

Review 4.  Current Controversies: Are Free Vitamin Metabolite Levels a More Accurate Assessment of Vitamin D Status than Total Levels?

Authors:  Daniel D Bikle; Sofie Malmstroem; Janice Schwartz
Journal:  Endocrinol Metab Clin North Am       Date:  2017-12       Impact factor: 4.741

5.  Measurement of 25-hydroxyvitamin D(2&3) and 1,25-dihydroxyvitamin D(2&3) by tandem mass spectrometry: A primate multispecies comparison.

Authors:  Toni E Ziegler; Amita Kapoor; Curtis J Hedman; Neil Binkley; Joseph W Kemnitz
Journal:  Am J Primatol       Date:  2015-04-02       Impact factor: 2.371

6.  Transgenic Mice Overexpressing Vitamin D Receptor (VDR) Show Anti-Inflammatory Effects in Lung Tissues.

Authors:  Masaki Ishii; Yasuhiro Yamaguchi; Kyoko Isumi; Sumito Ogawa; Masahiro Akishita
Journal:  Inflammation       Date:  2017-12       Impact factor: 4.092

Review 7.  Endogenously produced nonclassical vitamin D hydroxy-metabolites act as "biased" agonists on VDR and inverse agonists on RORα and RORγ.

Authors:  Andrzej T Slominski; Tae-Kang Kim; Judith V Hobrath; Allen S W Oak; Edith K Y Tang; Elaine W Tieu; Wei Li; Robert C Tuckey; Anton M Jetten
Journal:  J Steroid Biochem Mol Biol       Date:  2016-09-28       Impact factor: 4.292

8.  Mechanisms of vitamin D₃ metabolite repression of IgE-dependent mast cell activation.

Authors:  Kwok-Ho Yip; Natasha Kolesnikoff; Chunping Yu; Nicholas Hauschild; Houng Taing; Lisa Biggs; David Goltzman; Philip A Gregory; Paul H Anderson; Michael S Samuel; Stephen J Galli; Angel F Lopez; Michele A Grimbaldeston
Journal:  J Allergy Clin Immunol       Date:  2014-01-22       Impact factor: 10.793

9.  25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance).

Authors:  Katherine Van Loon; Kouros Owzar; Chen Jiang; Hedy L Kindler; Mary F Mulcahy; Donna Niedzwiecki; Eileen M O'Reilly; Charles Fuchs; Federico Innocenti; Alan P Venook
Journal:  J Natl Cancer Inst       Date:  2014-08-06       Impact factor: 13.506

10.  Vitamin D, leptin and impact on immune response to seasonal influenza A/H1N1 vaccine in older persons.

Authors:  Sapna P Sadarangani; Inna G Ovsyannikova; Krista Goergen; Diane E Grill; Gregory A Poland
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.